当前位置:首页 - 行情中心 - 莱茵生物(002166) - 财务分析

莱茵生物

(002166)

  

流通市值:64.85亿  总市值:65.11亿
流通股本:7.39亿   总股本:7.42亿

莱茵生物(002166)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.43亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益327208.71万元,未分配利润88907.38万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产512639.56万元,负债185430.85万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入446,871,087.432,043,836,317.71,272,155,817.35836,964,658.02
营业总成本401,670,515.611,858,906,809.191,186,425,574.15784,217,763.94
其他经营收益
营业利润51,611,457.2204,966,827.63106,582,077.9263,289,124.83
利润总额51,595,809.06200,700,725.07104,929,663.0462,366,236.59
净利润42,640,384.59152,883,586.2779,191,843.5643,672,421.11
每股收益
其他综合收益-10,543,840.78-6,907,607.08-1,069,684.732,319,069.71
综合收益总额32,096,543.81145,975,979.1978,122,158.8345,991,490.82
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,768,035,071.142,991,206,272.192,570,216,019.082,503,498,554.96
非流动资产:
非流动资产合计2,358,360,565.872,390,839,707.552,414,856,218.712,396,329,739.45
资产总计5,126,395,637.015,382,045,979.744,985,072,237.794,899,828,294.41
流动负债:
流动负债合计1,568,032,061.11,873,530,695.921,490,169,063.631,525,768,797.63
非流动负债:
非流动负债合计286,276,487.01268,524,738.73332,595,507.44244,522,498.07
负债合计1,854,308,548.112,142,055,434.651,822,764,571.071,770,291,295.7
所有者权益(或股东权益):
归属于母公司股东权益合计3,188,307,531.13,156,334,837.73,076,548,372.753,047,011,853.01
股东权益合计3,272,087,088.93,239,990,545.093,162,307,666.723,129,536,998.71
负债和股东权益合计5,126,395,637.015,382,045,979.744,985,072,237.794,899,828,294.41
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计820,952,930.981,929,960,753.891,518,730,522.971,082,710,675.2
经营活动现金流出小计508,082,737.771,769,752,655.091,172,272,820.74787,933,475.13
经营活动产生的现金流量净额312,870,193.21160,208,098.8346,457,702.23294,777,200.07
投资活动产生的现金流量:
投资活动现金流入小计289,924.188,575,943.085,538,573.33500,235.35
投资活动现金流出小计38,501,822.49162,162,280.89120,246,861.4885,226,314.72
投资活动产生的现金流量净额-38,211,898.31-153,586,337.81-114,708,288.15-84,726,079.37
筹资活动产生的现金流量:
筹资活动现金流入小计206,000,0001,353,448,408.5802,448,408.5503,848,408.5
筹资活动现金流出小计248,064,512.321,345,838,532.37946,548,653.54641,193,667
筹资活动产生的现金流量净额-42,064,512.327,609,876.13-144,100,245.04-137,345,258.5
汇率变动对现金及现金等价物的影响-2,144,401.331,150,099.231,492,697.061,563,464.92
现金及现金等价物净增加额230,449,381.2515,381,736.3589,141,866.174,269,327.12
期末现金及现金等价物余额295,600,523.9565,151,142.7138,911,272.45124,038,733.47
补充资料:
现金及现金等价物的净增加额-15,381,736.35-74,269,327.12
最新报告期:2026-04-07
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
浙商证券杜宛泽0.250.300.352026-04-07
华鑫证券孙山山,胡博新0.250.340.422026-04-03
中信证券李超,郭柯宇0.290.390.482026-04-03
TOP↑